Document Detail

Clinical features of acute renal failure associated with hepatitis A virus infection.
MedLine Citation:
PMID:  19824944     Owner:  NLM     Status:  In-Process    
Acute hepatitis A (AHA) is one of the most common infectious diseases; it is usually a self-limiting disease affecting the liver. Although extrahepatic manifestations are not common, some cases have been reported associated with acute renal failure. We reviewed the clinical features of patients with AHA complicated by acute renal failure (ARF group) and compared them with patients with noncomplicated AHA (non-ARF group). The medical records of 208 consecutive patients with AHA who were diagnosed between January 2003 and October 2008 were reviewed. We identified 15 patients (7.2%) with ARF associated with AHA. There were no differences between the ARF and non-ARF group with regard to gender and age. The peak value of alanine aminotransferase (ALT) (median: 6060 IU/L vs 1792 IU/L, P < 0.001), prothrombin time (PT) (International normalized ratio, median 1.72 vs 1.10, P < 0.001), and total bilirubin level (median: 9.6 mg/dL vs 6.3 mg/dL, P = 0.04) were significantly higher in the ARF than in the non-ARF group. Twelve patients (80%) recovered completely with haemodialysis (seven patients, 46.7%) or only conservative management (five patients, 33.3%), while one patient underwent liver transplantation because of fulminant hepatic failure, and two patients died because of fulminant hepatic failure. There were no deaths among patients with noncomplicated AHA in the non-ARF group. Five patients underwent kidney biopsy; two patients were diagnosed with acute tubular necrosis, two patients with acute interstitial nephritis with IgA nephropathy and one patient with acute tubulointerstitial nephritis. All patients in the ARF group had microscopic haematuria and proteinuria (100%vs 31.1%, P < 0.001). Urine sodium levels were more than 10 mEq/L in 10 patients. The findings of high urinary sodium concentrations, microscopic haematuria and proteinuria did not support the diagnosis of hepatorenal syndrome (HRS). Patients with AHA with ARF had higher ALT levels, more prolonged PTs, and higher total bilirubin levels. The prognosis for these patients was poorer than for those without ARF. However, the patients with ARF and nonfulminant AHA had recovered with proper treatment and should not be confused with patients that have HRS.
Y J Jung; W Kim; J B Jeong; B G Kim; K L Lee; K-H Oh; J-H Yoon; H-S Lee; Y J Kim
Related Documents :
12078944 - Tolerance of mycophenolate mofetil in end-stage renal disease patients with anca-associ...
9681714 - Has the prognosis for patients with pauci-immune necrotizing glomerulonephritis improved?
12422004 - Effectiveness of tnf-alpha blockade with infliximab in refractory wegener's granulomato...
11728994 - A case of familial mediterranean fever with amyloidosis as the first manifestation.
17725924 - Cyclosporin a treatment is associated with increased serum immunoglobulin e levels in a...
46724 - The roentgenographic and clinical findings in whipple's disease. a review of 8 patients.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-10-11
Journal Detail:
Title:  Journal of viral hepatitis     Volume:  17     ISSN:  1365-2893     ISO Abbreviation:  J. Viral Hepat.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435672     Medline TA:  J Viral Hepat     Country:  England    
Other Details:
Languages:  eng     Pagination:  611-7     Citation Subset:  IM    
Department of Internal Medicine, Seoul National University College of Medicine, Seoul Municipal Boramae Hospital, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exposure to traffic exhaust and night cough during early childhood: the CCAAPS birth cohort.
Next Document:  Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves susta...